Pediatric Pulmonary hypertension is a rare chronic disease of the lungs and often results in numerous challenges including breathing abnormalities. Upon diagnosis, standard procedure for Pediatric PH involves Acute Vasoreactivity Testing (AVT), a strong predictor of prognosis and treatment options. The goal of this longitudinal study was to identify AVT results as a potential prognostic factor in the treatment of pediatric PH patients.